Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
NCT01690065
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Chronic Myeloid Leukemia in Myeloid Blast Crisis
Untreated Adult Acute Myeloid Leukemia
Interventions
DRUG:
Nilotinib+AD induction
Sponsor
Ulsan University Hospital
Collaborators
[object Object]